Alx Oncology Holdings
Price & Volume
Stats
See more52W Range | $1.19-$17.82 |
Market Cap | $79.6M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $107,000 |
Diluted EPS | -$2.97 |
News
See moreYahoo Finance • last year
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Yahoo Finance • last year
ALX Oncology Announces November Investor Conference Participation
Yahoo Finance • last year
ALX Oncology Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Yahoo Finance • last year
ALX Oncology Announces Pricing of Public Offering
About
CEO | Mr. Jason W. Lettmann |
Address | 323 Allerton Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 89 |
